GliGene AB

GliGene AB develops antagonists to the Hedgehog pathway for the treatment of solid tumors. The company discovers, develops, and commercializes new targeted therapies for cancer patients.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Website
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Fogdevreten 2 A 171 65
Solna,
Sweden
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]